Fierce Pharma

OCTOBER 10, 2023

What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer (NSCLC) could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Ke | What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Keytruda.

Doctors 294

Doctors FDA 294

MedCity News

OCTOBER 10, 2023

Formed by Baidu founder and CEO Robin Li, BioMap uses artificial intelligence technology to glean insight into proteins to guide biologic drug discovery. The startup is the latest company to join a growing list of Sanofi partners as the pharmaceutical giant continues investing in AI-enabled drug discovery.

Pharmaceutical 122

Pharmaceutical Biopharma Pharma 122

Fierce Pharma

OCTOBER 10, 2023

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. | Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Now, as BlueRock Therapeutics advances its lead prospect, its parent company Bayer is ready to kick production into high gear.

Prospecting 274

Prospecting Manufacturing Medicine Leads 274

Copyright Clearance Center

OCTOBER 10, 2023

October 10, 2023 – Danvers, Mass. – CCC , the leading provider of Open Access (OA) workflow solutions, announces new data import capabilities and AI-enabled affiliation matching in its OA Agreement Intelligence modeling and analytics tool that provides publishers with a 360-degree view of disambiguated publication data to build accurate, transparent institutional offers regarding OA.

Training 118

Training Government Management Leads 118

Advertisement

Distribution

Fierce Pharma

OCTOBER 10, 2023

Personalization—we’re all talking about it, and we’re all trying to do it better. So what sets Veradigm apart? | Veradigm has insights as to how personalized and targeted messaging can drive awareness and engagement, ultimately improving the patient experience.

Patients 225

Patients 225

MedCity News

OCTOBER 10, 2023

Merith Basey, executive director of Patients For Affordable Drugs, believes the Medicare price negotiation program is here to stay, no matter who is president and no matter how many Big Pharma players file lawsuits. Her reasoning? Every other high income nation has been negotiating prices with drugmakers for years, and the program is widely popular in the U.S. among pretty much everyone who isn’t a pharma company, she said during a session at Engage at HLTH.

Pharma 111

Pharma Patients Biopharma 111

MedCity News

OCTOBER 10, 2023

Bayer opens its new cell therapy manufacturing facility as it prepares a Parkinson’s disease cell therapy for Phase 2 testing. The new 100,000 square foot facility also has space for manufacturing other cell therapies in the pharma giant’s pipeline.

Manufacturing 106

Manufacturing Pharma Biopharma 106

Fierce Pharma

OCTOBER 10, 2023

Roche has presented data that show Vabysmo can maintain visual gains in RVO with a dosing duration stretched to as long as once every four months.

161

161

MedCity News

OCTOBER 10, 2023

The report maps out the health tech sector’s current position in the innovation hype cycle, which business models are most resilient, and how the industry can move out of the trough of disillusionment. It also offered predictions for health tech trends in 2024.

105

105

European Pharmaceutical Review

OCTOBER 10, 2023

Schneider Electric, a leader in digital transformation, energy management and automation, has announced the speaker lineup for its exclusive event, Life Sciences Innovation Day – Accelerating Digital Transformation Ambition. Set at the world-renowned Silverstone F1 Racetrack on 18 October 2023, it promises to be a day of immersive insights and top rate networking.

Engineering 101

Engineering Networking Manufacturing Consulting 101

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

OCTOBER 10, 2023

Spring Health and Highmark Health are collaborating to launch Mental Well-Being, a solution that offers therapy, medication and other services for some Highmark members.

Medical 105

Medical 105

Pharmaceutical Technology

OCTOBER 10, 2023

In a two-part column, F. Randy Vogenberg delves into why it is important to address emerging challenges in the employer-based US commercial insurance landscape.

Insurance 98

Insurance 98

MedCity News

OCTOBER 10, 2023

Main Street Health announced the close of a $315 funding round at HLTH — some of the investors included UnitedHealthcare, Humana, Elevance, Centene and CVS. The startup, which scales value-based care in rural areas for both Medicare Advantage and original Medicare patients, also announced that it is expanding to 26 states.

Patients 91

Patients 91

European Pharmaceutical Review

OCTOBER 10, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD). This treatment is an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor.

Safety 88

Safety Leads Patients Pharmaceutical 88

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Eversana Intouch

OCTOBER 10, 2023

Fact 1: Pharma is in the business of discovering, developing, and producing drugs with the aim of treating, curing, or preventing diseases…ultimately leading to healthier communities around the world. Fact 2: Pharma is just that – a business. Both facts are true. Both facts co-exist. And both facts impact how society views our industry. On that last point, there have clearly been times where Fact 2 has a direct influence on Fact 1.

Pharma 87

Pharma Marketing Media Medical 87

PharmaTimes

OCTOBER 10, 2023

The scheme will help ten projects establish research and innovation clusters - News - PharmaTimes

116

116

PharmaVoice

OCTOBER 10, 2023

A study aimed at helping astronauts decrease bone loss could open the door to novel osteoporosis meds.

111

111

Copyright Clearance Center

OCTOBER 10, 2023

The upcoming Frankfurter Buchmesse has programming looking at many aspects of artificial intelligence and related issues…

98

98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmaceutical Technology

OCTOBER 10, 2023

The Gates Foundation is providing $40m in funding to advance the accessibility of Quantoom Biosciences' affordable mRNA vaccine platform.

93

93

PharmaTimes

OCTOBER 10, 2023

Researchers focused on four of the most common heart conditions in the UK - News - PharmaTimes

100

100

Pharmaceutical Commerce

OCTOBER 10, 2023

Session offers insight on how to successfully implement cold chain transport.

Transportation 105

Transportation 105

Clarify Health

OCTOBER 10, 2023

Social determinants of health (SDoH) play a significant role in the overall health and well-being of individuals and communities. When building provider networks, it is crucial to include providers who can assess and address social determinants to ensure that care is equitable, patient-centered, and effective in improving health outcomes and reducing healthcare disparities.

Networking 59

Networking Education Healthcare Healthcare 59

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PharmExec

OCTOBER 10, 2023

Site aims to advance regenerative medicines on a global scale.

Manufacturing 98

Manufacturing Medicine 98

PharmaTech

OCTOBER 10, 2023

Developing and manufacturing complex novel oral solid dose products of highly potent compounds requires specialized expertise. Learn more about creating a safe, efficient and scalable drug development program with HPAPIs in this eBook.

Manufacturing 52

Manufacturing Specialization 52

Legacy MEDSearch

OCTOBER 10, 2023

Intelivation Technologies, an innovative medical device company with a cutting-edge orthopedic portfolio announced today that it has received clearance from the Food and Drug Administration for its Hammerdesis Interphalangeal Fusion System. Hammerdesis allows surgeons to correct hammertoe deformities and degenerative issues in patients by simply affixing a distinctively designed implant on the patient’s toe joint.

Food and Drug Administration 52

Food and Drug Administration FDA Recruitment Marketing 52

PharmaTech

OCTOBER 10, 2023

Central to a successful technology transfer is effective project management. This white paper discusses the role of project management at Jubilant HollisterStier in creating and executing transfer plans and the innovative solutions developed for the transfer of five COVID-19 vaccine and therapeutic fill finish manufacturing projects.

Management 52

Management Manufacturing 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharmaceutical Technology

OCTOBER 10, 2023

As sponsors seek to minimize trial delays and get new therapies to market faster, we explore whether increased adoption of a more patient-centric approach could make a difference to timelines.

Leads 52

Leads Marketing Patients 52

PharmaTech

OCTOBER 10, 2023

Bassem Gayed, PhD, Senior Technical Director of CAR-T Process Engineering, Manufacturing Science & Technology at Bristol Myers Squibb, discusses the connection of process validation and CAR-T processes.

Engineering 52

Engineering Manufacturing FDA 52

pharmaphorum

OCTOBER 10, 2023

Bayer backs cell therapy ambition with $250m US facility Phil.

89

89

Pharmaceutical Technology

OCTOBER 10, 2023

ABVC BioPharma has obtained a patent in Taiwan for the usage of PDC-1421 in ABV-1504, an asset intended for major depressive disorder.

Biopharma 59

Biopharma 59

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management